Global Allogeneic Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

Page: 105

Published Date: 22 Apr 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Allogeneic Stem Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Allogeneic Stem Cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Allogeneic Stem Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Allogeneic Stem Cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Allogeneic Stem Cell Therapy total market, 2018-2029, (USD Million)
Global Allogeneic Stem Cell Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Allogeneic Stem Cell Therapy total market, key domestic companies and share, (USD Million)
Global Allogeneic Stem Cell Therapy revenue by player and market share 2018-2023, (USD Million)
Global Allogeneic Stem Cell Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Allogeneic Stem Cell Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Allogeneic Stem Cell Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen and MolMed S.p.A., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Allogeneic Stem Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Allogeneic Stem Cell Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Allogeneic Stem Cell Therapy Market, Segmentation by Type
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others

Global Allogeneic Stem Cell Therapy Market, Segmentation by Application
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others

Companies Profiled:
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)

Key Questions Answered
1. How big is the global Allogeneic Stem Cell Therapy market?
2. What is the demand of the global Allogeneic Stem Cell Therapy market?
3. What is the year over year growth of the global Allogeneic Stem Cell Therapy market?
4. What is the total value of the global Allogeneic Stem Cell Therapy market?
5. Who are the major players in the global Allogeneic Stem Cell Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Allogeneic Stem Cell Therapy Introduction
    1.2 World Allogeneic Stem Cell Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Allogeneic Stem Cell Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Allogeneic Stem Cell Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Allogeneic Stem Cell Therapy Market Size (2018-2029)
        1.3.3 China Allogeneic Stem Cell Therapy Market Size (2018-2029)
        1.3.4 Europe Allogeneic Stem Cell Therapy Market Size (2018-2029)
        1.3.5 Japan Allogeneic Stem Cell Therapy Market Size (2018-2029)
        1.3.6 South Korea Allogeneic Stem Cell Therapy Market Size (2018-2029)
        1.3.7 ASEAN Allogeneic Stem Cell Therapy Market Size (2018-2029)
        1.3.8 India Allogeneic Stem Cell Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Allogeneic Stem Cell Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Allogeneic Stem Cell Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.2 World Allogeneic Stem Cell Therapy Consumption Value by Region
        2.2.1 World Allogeneic Stem Cell Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Allogeneic Stem Cell Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.4 China Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.5 Europe Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.6 Japan Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.7 South Korea Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.8 ASEAN Allogeneic Stem Cell Therapy Consumption Value (2018-2029)
    2.9 India Allogeneic Stem Cell Therapy Consumption Value (2018-2029)

3 World Allogeneic Stem Cell Therapy Companies Competitive Analysis
    3.1 World Allogeneic Stem Cell Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Allogeneic Stem Cell Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Allogeneic Stem Cell Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Allogeneic Stem Cell Therapy in 2022
    3.3 Allogeneic Stem Cell Therapy Company Evaluation Quadrant
    3.4 Allogeneic Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.4.1 Allogeneic Stem Cell Therapy Market: Region Footprint
        3.4.2 Allogeneic Stem Cell Therapy Market: Company Product Type Footprint
        3.4.3 Allogeneic Stem Cell Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Allogeneic Stem Cell Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Allogeneic Stem Cell Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Allogeneic Stem Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Allogeneic Stem Cell Therapy Consumption Value Comparison
        4.2.1 United States VS China: Allogeneic Stem Cell Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Allogeneic Stem Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Allogeneic Stem Cell Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Allogeneic Stem Cell Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Allogeneic Stem Cell Therapy Revenue, (2018-2023)
    4.4 China Based Companies Allogeneic Stem Cell Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Allogeneic Stem Cell Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Allogeneic Stem Cell Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Allogeneic Stem Cell Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Allogeneic Stem Cell Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Allogeneic Stem Cell Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Allogeneic Stem Cell Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Adult Stem Cell Therapy
        5.2.2 Human Embryonic Stem Cell Therapy
        5.2.3 Induced Pluripotent Stem Cell Therapy
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Allogeneic Stem Cell Therapy Market Size by Type (2018-2023)
        5.3.2 World Allogeneic Stem Cell Therapy Market Size by Type (2024-2029)
        5.3.3 World Allogeneic Stem Cell Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Allogeneic Stem Cell Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Musculoskeletal Disorder
        6.2.2 Wounds & Injuries
        6.2.3 Cardiovascular Diseases
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Allogeneic Stem Cell Therapy Market Size by Application (2018-2023)
        6.3.2 World Allogeneic Stem Cell Therapy Market Size by Application (2024-2029)
        6.3.3 World Allogeneic Stem Cell Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Escape Therapeutics, Inc.
        7.1.1 Escape Therapeutics, Inc. Details
        7.1.2 Escape Therapeutics, Inc. Major Business
        7.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product and Services
        7.1.4 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Escape Therapeutics, Inc. Recent Developments/Updates
        7.1.6 Escape Therapeutics, Inc. Competitive Strengths & Weaknesses
    7.2 Lonza Group Ltd.
        7.2.1 Lonza Group Ltd. Details
        7.2.2 Lonza Group Ltd. Major Business
        7.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Product and Services
        7.2.4 Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Lonza Group Ltd. Recent Developments/Updates
        7.2.6 Lonza Group Ltd. Competitive Strengths & Weaknesses
    7.3 Osiris Therapeutics (Smith & Nephew)
        7.3.1 Osiris Therapeutics (Smith & Nephew) Details
        7.3.2 Osiris Therapeutics (Smith & Nephew) Major Business
        7.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product and Services
        7.3.4 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Osiris Therapeutics (Smith & Nephew) Recent Developments/Updates
        7.3.6 Osiris Therapeutics (Smith & Nephew) Competitive Strengths & Weaknesses
    7.4 NuVasive
        7.4.1 NuVasive Details
        7.4.2 NuVasive Major Business
        7.4.3 NuVasive Allogeneic Stem Cell Therapy Product and Services
        7.4.4 NuVasive Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 NuVasive Recent Developments/Updates
        7.4.6 NuVasive Competitive Strengths & Weaknesses
    7.5 Chiesi Pharmaceuticals
        7.5.1 Chiesi Pharmaceuticals Details
        7.5.2 Chiesi Pharmaceuticals Major Business
        7.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product and Services
        7.5.4 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Chiesi Pharmaceuticals Recent Developments/Updates
        7.5.6 Chiesi Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 JCR Pharmaceutical
        7.6.1 JCR Pharmaceutical Details
        7.6.2 JCR Pharmaceutical Major Business
        7.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Product and Services
        7.6.4 JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 JCR Pharmaceutical Recent Developments/Updates
        7.6.6 JCR Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Pharmicell
        7.7.1 Pharmicell Details
        7.7.2 Pharmicell Major Business
        7.7.3 Pharmicell Allogeneic Stem Cell Therapy Product and Services
        7.7.4 Pharmicell Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Pharmicell Recent Developments/Updates
        7.7.6 Pharmicell Competitive Strengths & Weaknesses
    7.8 Anterogen
        7.8.1 Anterogen Details
        7.8.2 Anterogen Major Business
        7.8.3 Anterogen Allogeneic Stem Cell Therapy Product and Services
        7.8.4 Anterogen Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Anterogen Recent Developments/Updates
        7.8.6 Anterogen Competitive Strengths & Weaknesses
    7.9 MolMed S.p.A.
        7.9.1 MolMed S.p.A. Details
        7.9.2 MolMed S.p.A. Major Business
        7.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Product and Services
        7.9.4 MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 MolMed S.p.A. Recent Developments/Updates
        7.9.6 MolMed S.p.A. Competitive Strengths & Weaknesses
    7.10 Takeda (TiGenix)
        7.10.1 Takeda (TiGenix) Details
        7.10.2 Takeda (TiGenix) Major Business
        7.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Product and Services
        7.10.4 Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Takeda (TiGenix) Recent Developments/Updates
        7.10.6 Takeda (TiGenix) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Allogeneic Stem Cell Therapy Industry Chain
    8.2 Allogeneic Stem Cell Therapy Upstream Analysis
    8.3 Allogeneic Stem Cell Therapy Midstream Analysis
    8.4 Allogeneic Stem Cell Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Allogeneic Stem Cell Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Allogeneic Stem Cell Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Allogeneic Stem Cell Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Allogeneic Stem Cell Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Allogeneic Stem Cell Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Allogeneic Stem Cell Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Allogeneic Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Allogeneic Stem Cell Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Allogeneic Stem Cell Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Allogeneic Stem Cell Therapy Players in 2022
    Table 12. World Allogeneic Stem Cell Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Allogeneic Stem Cell Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Allogeneic Stem Cell Therapy Player
    Table 15. Allogeneic Stem Cell Therapy Market: Company Product Type Footprint
    Table 16. Allogeneic Stem Cell Therapy Market: Company Product Application Footprint
    Table 17. Allogeneic Stem Cell Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Allogeneic Stem Cell Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Allogeneic Stem Cell Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Allogeneic Stem Cell Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Allogeneic Stem Cell Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Allogeneic Stem Cell Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Allogeneic Stem Cell Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Allogeneic Stem Cell Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Allogeneic Stem Cell Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Allogeneic Stem Cell Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Allogeneic Stem Cell Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Allogeneic Stem Cell Therapy Revenue Market Share (2018-2023)
    Table 29. World Allogeneic Stem Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Allogeneic Stem Cell Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Allogeneic Stem Cell Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Allogeneic Stem Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Allogeneic Stem Cell Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Allogeneic Stem Cell Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Escape Therapeutics, Inc. Basic Information, Area Served and Competitors
    Table 36. Escape Therapeutics, Inc. Major Business
    Table 37. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product and Services
    Table 38. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Escape Therapeutics, Inc. Recent Developments/Updates
    Table 40. Escape Therapeutics, Inc. Competitive Strengths & Weaknesses
    Table 41. Lonza Group Ltd. Basic Information, Area Served and Competitors
    Table 42. Lonza Group Ltd. Major Business
    Table 43. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product and Services
    Table 44. Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Lonza Group Ltd. Recent Developments/Updates
    Table 46. Lonza Group Ltd. Competitive Strengths & Weaknesses
    Table 47. Osiris Therapeutics (Smith & Nephew) Basic Information, Area Served and Competitors
    Table 48. Osiris Therapeutics (Smith & Nephew) Major Business
    Table 49. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product and Services
    Table 50. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Osiris Therapeutics (Smith & Nephew) Recent Developments/Updates
    Table 52. Osiris Therapeutics (Smith & Nephew) Competitive Strengths & Weaknesses
    Table 53. NuVasive Basic Information, Area Served and Competitors
    Table 54. NuVasive Major Business
    Table 55. NuVasive Allogeneic Stem Cell Therapy Product and Services
    Table 56. NuVasive Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. NuVasive Recent Developments/Updates
    Table 58. NuVasive Competitive Strengths & Weaknesses
    Table 59. Chiesi Pharmaceuticals Basic Information, Area Served and Competitors
    Table 60. Chiesi Pharmaceuticals Major Business
    Table 61. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product and Services
    Table 62. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Chiesi Pharmaceuticals Recent Developments/Updates
    Table 64. Chiesi Pharmaceuticals Competitive Strengths & Weaknesses
    Table 65. JCR Pharmaceutical Basic Information, Area Served and Competitors
    Table 66. JCR Pharmaceutical Major Business
    Table 67. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product and Services
    Table 68. JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. JCR Pharmaceutical Recent Developments/Updates
    Table 70. JCR Pharmaceutical Competitive Strengths & Weaknesses
    Table 71. Pharmicell Basic Information, Area Served and Competitors
    Table 72. Pharmicell Major Business
    Table 73. Pharmicell Allogeneic Stem Cell Therapy Product and Services
    Table 74. Pharmicell Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Pharmicell Recent Developments/Updates
    Table 76. Pharmicell Competitive Strengths & Weaknesses
    Table 77. Anterogen Basic Information, Area Served and Competitors
    Table 78. Anterogen Major Business
    Table 79. Anterogen Allogeneic Stem Cell Therapy Product and Services
    Table 80. Anterogen Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Anterogen Recent Developments/Updates
    Table 82. Anterogen Competitive Strengths & Weaknesses
    Table 83. MolMed S.p.A. Basic Information, Area Served and Competitors
    Table 84. MolMed S.p.A. Major Business
    Table 85. MolMed S.p.A. Allogeneic Stem Cell Therapy Product and Services
    Table 86. MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. MolMed S.p.A. Recent Developments/Updates
    Table 88. Takeda (TiGenix) Basic Information, Area Served and Competitors
    Table 89. Takeda (TiGenix) Major Business
    Table 90. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product and Services
    Table 91. Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Allogeneic Stem Cell Therapy Upstream (Raw Materials)
    Table 93. Allogeneic Stem Cell Therapy Typical Customers
List of Figure
    Figure 1. Allogeneic Stem Cell Therapy Picture
    Figure 2. World Allogeneic Stem Cell Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Allogeneic Stem Cell Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Allogeneic Stem Cell Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Allogeneic Stem Cell Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Allogeneic Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Allogeneic Stem Cell Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Allogeneic Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Allogeneic Stem Cell Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Allogeneic Stem Cell Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Allogeneic Stem Cell Therapy Markets in 2022
    Figure 27. United States VS China: Allogeneic Stem Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Allogeneic Stem Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Allogeneic Stem Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Allogeneic Stem Cell Therapy Market Size Market Share by Type in 2022
    Figure 31. Adult Stem Cell Therapy
    Figure 32. Human Embryonic Stem Cell Therapy
    Figure 33. Induced Pluripotent Stem Cell Therapy
    Figure 34. Others
    Figure 35. World Allogeneic Stem Cell Therapy Market Size Market Share by Type (2018-2029)
    Figure 36. World Allogeneic Stem Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Allogeneic Stem Cell Therapy Market Size Market Share by Application in 2022
    Figure 38. Musculoskeletal Disorder
    Figure 39. Wounds & Injuries
    Figure 40. Cardiovascular Diseases
    Figure 41. Others
    Figure 42. Allogeneic Stem Cell Therapy Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)

Related Reports

Global Allogeneic Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Allogeneic Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Allogeneic Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Allogeneic Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Allogeneic Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Allogeneic Stem Cell Therapy market size was valued at USD 779.2 million in 2023 and is forecast to a readjusted size of USD 1513.9 million by 2030 with a CAGR of 10.0% during review period.

Product Tags

Allogeneic Stem Cell Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>